Abbot Financial Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.65M | Buy |
14,925
+29
| +0.2% | +$6.75K | 1.52% | 16 |
|
|
2025
Q4 | $3.08M | Sell |
14,896
-66
| -0.4% | -$13.1K | 1.28% | 20 |
|
|
2025
Q3 | $2.77M | Sell |
14,962
-289
| -2% | -$49.5K | 1.19% | 21 |
|
|
2025
Q2 | $2.33M | Sell |
15,251
-34
| -0.2% | -$5.23K | 1.07% | 23 |
|
|
2025
Q1 | $2.53M | Sell |
15,285
-505
| -3% | -$79K | 1.32% | 20 |
|
|
2024
Q4 | $2.28M | Sell |
15,790
-188
| -1% | -$29.1K | 1.14% | 22 |
|
|
2024
Q3 | $2.59M | Sell |
15,978
-499
| -3% | -$79.5K | 1.3% | 21 |
|
|
2024
Q2 | $2.41M | Sell |
16,477
-519
| -3% | -$77.2K | 1.29% | 20 |
|
|
2024
Q1 | $2.69M | Sell |
16,996
-574
| -3% | -$91.4K | 1.48% | 17 |
|
|
2023
Q4 | $2.75M | Buy |
17,570
+261
| +2% | +$40K | 1.66% | 15 |
|
|
2023
Q3 | $2.7M | Sell |
17,309
-135
| -0.8% | -$22.3K | 1.81% | 13 |
|
|
2023
Q2 | $2.89M | Sell |
17,444
-203
| -1% | -$32.8K | 1.85% | 13 |
|
|
2023
Q1 | $2.74M | Sell |
17,647
-51
| -0.3% | -$8.23K | 1.84% | 15 |
|
|
2022
Q4 | $3.13M | Buy |
17,698
+301
| +2% | +$52K | 2.14% | 12 |
|
|
2022
Q3 | $2.84M | Sell |
17,397
-2,908
| -14% | -$492K | 2.02% | 12 |
|
|
2022
Q2 | $3.6M | Sell |
20,305
-99
| -0.5% | -$17.6K | 2.18% | 8 |
|
|
2022
Q1 | $3.62M | Sell |
20,404
-1,225
| -6% | -$208K | 1.77% | 12 |
|
|
2021
Q4 | $3.7M | Buy |
21,629
+128
| +0.6% | +$21K | 1.65% | 14 |
|
|
2021
Q3 | $3.47M | Hold |
21,501
| – | – | 1.58% | 14 |
|
|
2021
Q2 | $3.54M | Sell |
21,501
-449
| -2% | -$74.3K | 1.55% | 13 |
|
|
2021
Q1 | $3.61M | Hold |
21,950
| – | – | 1.64% | 12 |
|
|
2020
Q4 | $3.45M | Sell |
21,950
-675
| -3% | -$99.6K | 1.99% | 12 |
|
|
2020
Q3 | $3.37M | Sell |
22,625
-200
| -0.9% | -$29.6K | 2.19% | 7 |
|
|
2020
Q2 | $3.21M | Sell |
22,825
-200
| -0.9% | -$29.1K | 2.21% | 9 |
|
|
2020
Q1 | $3.02M | Sell |
23,025
-200
| -0.9% | -$28.4K | 2.46% | 7 |
|
|
2019
Q4 | $3.39M | Buy |
23,225
+150
| +0.7% | +$20.3K | 2.15% | 9 |
|
|
2019
Q3 | $2.98M | Sell |
23,075
-50
| -0.2% | -$6.59K | 2.13% | 9 |
|
|
2019
Q2 | $3.22M | Sell |
23,125
-179
| -0.8% | -$24.8K | 2.33% | 8 |
|
|
2019
Q1 | $3.26M | Sell |
23,304
-375
| -2% | -$50.2K | 2.53% | 9 |
|
|
2018
Q4 | $3.06M | Sell |
23,679
-225
| -0.9% | -$31.4K | 2.69% | 9 |
|
|
2018
Q3 | $3.3M | Hold |
23,904
| – | – | 2.46% | 9 |
|
|
2018
Q2 | $2.9M | Sell |
23,904
-500
| -2% | -$62.4K | 2.31% | 9 |
|
|
2018
Q1 | $3.13M | Sell |
24,404
-65
| -0.3% | -$8.79K | 2.51% | 8 |
|
|
2017
Q4 | $3.42M | Sell |
24,469
-111
| -0.5% | -$15.5K | 2.73% | 6 |
|
|
2017
Q3 | $3.48M | Buy |
24,580
+950
| +4% | +$126K | 2.9% | 4 |
|
|
2017
Q2 | $3.13M | Buy |
+23,630
| New | +$3.01M | 2.8% | 4 |
|
Other funds holding JNJ
VCM
VPM
Abbot Financial Management's JNJ Position: Q1 2026 in Review
Abbot Financial Management increased its Johnson & Johnson (JNJ) stake by 0.19% in Q1 2026, buying an estimated $6.75K and bringing the position to 14,925 shares worth $3.65M. The position accounts for 1.52% of the portfolio, ranked #16.
Abbot Financial Management first reported a position in JNJ in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.7M in Q4 2021. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Abbot Financial Management held 14,925 shares of Johnson & Johnson worth $3.65M as of Q1 2026.
- Abbot Financial Management bought 29 Johnson & Johnson shares in Q1 2026, an estimated $6.75K.
- Johnson & Johnson made up 1.52% of Abbot Financial Management's portfolio in Q1 2026, its #16 holding.
- Abbot Financial Management first reported a position in Johnson & Johnson in Q2 2017 and has held it in 36 quarters since.
- Abbot Financial Management's Johnson & Johnson position peaked at $3.7M in Q4 2021.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Abbot Financial Management's 13F filing for Q1 2026, filed 13 May 2026.